Metraipolis › archive › dc_54916f8cede7
Implementation of neoadjuvant immunotherapy in stage III melanoma: a modified Delphi consensus study in a European-accredited cancer center in Ireland — Europe PMC PMID:40857557
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40857557
- DOI
- 10.1093/oncolo/oyaf265
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T05:30:12.504Z
- SHA-256 of the archived text
e0f22f4f3f47aa86174765779977451bd561481125a133a59859465796a8b71e- Stable URL of this page
https://metraipolis.com/documento/dc_54916f8cede7
How to cite
Implementation of neoadjuvant immunotherapy in stage III melanoma: a modified Delphi consensus study in a European-accredited cancer center in Ireland — Europe PMC PMID:40857557 — Europe PMC (en), https://europepmc.org/article/MED/40857557 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_54916f8cede7 (Metraipolis archive dc_54916f8cede7, sha256 e0f22f4f3f47aa86174765779977451bd561481125a133a59859465796a8b71e)
BibTeX
@misc{dc54916f8cede7,
title = {Implementation of neoadjuvant immunotherapy in stage III melanoma: a modified Delphi consensus study in a European-accredited cancer center in Ireland — Europe PMC PMID:40857557},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40857557},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_54916f8cede7; sha256 e0f22f4f3f47aa86174765779977451bd561481125a133a59859465796a8b71e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40857557. Agents can read the archived copy with the MCP tool read_document.